OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Light-Activated drug targets eye cancer in major trial
Disease control Recruiting nowThis study is testing a new drug called belzupacap sarotalocan for people with early-stage eye tumors. It aims to see if the drug, which is injected near the eye and activated with a laser, is safe and can stop the tumors from growing better than a sham (fake) procedure. The tria…
Matched conditions: OCULAR MELANOMA
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New Two-Pronged attack on Tough-to-Treat skin cancer
Disease control Recruiting nowThis study is testing a new, modified drug called IOV-3001 in combination with a personalized cell therapy (lifileucel) for people with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the body handles the …
Matched conditions: OCULAR MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duo targets rare, Hard-to-Treat eye cancer
Disease control Recruiting nowThis study is testing a combination of two existing drugs, olaparib and pembrolizumab, to see if they can work together to control advanced uveal melanoma, a rare and aggressive cancer that starts in the eye. It will involve about 37 adults whose cancer has spread. The main goal …
Matched conditions: OCULAR MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Researchers ask: how does eye cancer treatment affect daily life?
Knowledge-focused Recruiting nowThis study aims to understand how a specific eye cancer treatment affects patients' quality of life, symptoms, and daily functioning. It involves 15 people who are already enrolled in a related treatment trial. Researchers will collect feedback through online surveys over two yea…
Matched conditions: OCULAR MELANOMA
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC